N-MYC promotes cell proliferation through a direct transactivation of neuronal leucine-rich repeat protein-1 ( ) gene in neuroblastoma
Neuronal leucine-rich repeat protein-1 ( NLRR1 ) gene encodes a type I transmembrane protein with unknown function. We have previously described that NLRR1 gene is highly expressed in unfavorable neuroblastomas as compared with favorable tumors and its higher expression levels correlate significantl...
Gespeichert in:
Veröffentlicht in: | Oncogene 2008-10, Vol.27 (46), p.6075-6082 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Neuronal leucine-rich repeat protein-1 (
NLRR1
) gene encodes a type I transmembrane protein with unknown function. We have previously described that
NLRR1
gene is highly expressed in unfavorable neuroblastomas as compared with favorable tumors and its higher expression levels correlate significantly with poor clinical outcome. In this study, we have found that
NLRR1
gene is one of direct target genes for N-MYC and its gene product contributes to N-MYC-dependent growth promotion in neuroblastoma. Expression levels of
NLRR1
were significantly associated with those of N-
MYC
in various neuroblastoma cell lines as well as primary neuroblastoma tissues. Indeed, enforced expression of N-MYC resulted in a remarkable induction of the endogenous
NLRR1
. Consistent with these results, we have identified two functional E-boxes within the promoter region and intron 1 of
NLRR1
gene. Intriguingly, c-myc also transactivated
NLRR1
gene. Enforced expression of NLRR1 promoted cell proliferation and rendered cells resistant to serum deprivation. In support with these observations, small-interfering RNA-mediated knockdown of the endogenous
NLRR1
-reduced growth rate and sensitized cells to serum starvation. Collectively, our present findings provide a novel insight into understanding molecular mechanisms behind aggressive neuroblastoma with N-
MYC
amplification. |
---|---|
ISSN: | 0950-9232 1476-5594 |
DOI: | 10.1038/onc.2008.200 |